| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.037 | 0.5 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.034 | 0.6 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.031 | 0.6 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |